Changes in T-Cell Subsets Identify Responders to FcR-nonbinding Anti-Cd3 mAb (Teplizumab) in Patients With Type 1 Diabetes

European Journal of Immunology - United Kingdom
doi 10.1002/eji.201545708
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Alteration in CD8 + T Cell Subsets in Enterovirus-Infected Patients: An Alarming Factor for Type 1 Diabetes Mellitus

Kaohsiung Journal of Medical Sciences
Medicine
2018English

Changes in Autoreactive T Cell Avidity During Type 1 Diabetes Development

Clinical Immunology
AllergyImmunology
2009English

Teplizumab Delays Onset of Type 1 Diabetes Mellitus

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2019English

T-Cell Responses to Enterovirus Antigens in Children With Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2000English

CD4 T Cell Differentiation in Type 1 Diabetes

Clinical and Experimental Immunology
AllergyImmunology
2015English

Prevention of Type 1 Diabetes in the Rat With an Allele-Specific Anti–T-Cell Receptor Antibody

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Are T-Cell Responses to GAD65 Influential in Type 1 Diabetes?: FIG. 1.

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

A Variable CD3+ T-Cell Frequency in Peripheral Blood Lymphocytes Associated With Type 1 Diabetes Mellitus Development in the LEW.1AR1-iddm Rat

PLoS ONE
Multidisciplinary
2013English

Cellular Trace Element Changes in Type 1 Diabetes Patients

JCRPE Journal of Clinical Research in Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy